Hope Hygieia Statue: Medium, Myth, and Roman Culture
According to the website of the J. Paul Getty Museum in Los Angeles, The Hope Hygieia is a marble, life-sized statue of the ancient goddess of health that was originally discovered in the ancient Roman port of Ostia in 1797. It was originally owned by the British collector Sir Thomas Hope before being sold to William Randolph Hearst, who donated it to the city of Los Angeles in 1950. Over the years, the statue has been restored, de-restored to the condition in which it was originally found, the re-restored at the Getty Museum in 2006. This is a white marble statue with the clothing and hairstyle of a young Roman woman from an aristocratic background. The snake wrapped around her upper body is normal in Hygieia statues and symbolizes medicine and healing, while her expression is serene, gentle, graceful and virginal, which is how she was usually portrayed in ancient sculpture.
Government Regulations and Their Impact on Hospice Care
This paper focuses on how government regulations impact hospice. The paper starts off with an introduction to the hospice system that was revived by a nurse, Cecily Saunders, who then went on to become a physician, establishing one of the first modern hospices. The concept of total pain is explained in some detail. The body of the paper then includes the studies that have been conducted on patients and caregivers in hospice systems as well as on people who died after they were diagnosed with terminal illness resulting in death in six months following the prognosis. The overall conclusion that can be drawn here is that while in Japan there is a marked need for improving the Day hospice system, the American hospice industry is acting as a mature competing industry, which can be detrimental to the quality of services being provided.
Systematic review of ST-elevation myocardial infarction
OBJECTIVE: The door to balloon time is an important determinant of the prognosis of STEMI patients. To reduce D2B times, most centers implement a pre-hospital triage which involves the use of pre-hospital ECG to allow direct transfer of patients with confirmed STEMI to the PCI lab. Since most health facilities do not have PCI laboratories, a quick decision needs to be made regarding fibrinolytic therapy or transfer to a PCI facility. The most important factor determining this decision is the time taken from the onset of symptoms to arrival at a hospital facility and the predicted time duration for effective transfer. Through this systemic review, we sought to analyze the role of pre-hospital management in door to balloon time (D2B), door to needle (D2N) time and the long term mortality of STEMI patients.
Research Paper
Undergraduate
Advanced Practice Nurses and Prescriptive Authority
Advanced Practice Nurses and Prescriptive Authority
Though the roles of Clinical Nurse Specialist, Nurse Educator and Nurse Administrator are all vital to the health care industry, they are not allowed prescriptive authority per se. However, the role of Nurse Practitioner is intimately connected with the ability to prescribe medications. The developmental history of the Nurse Practitioner shows a determined movement from a single fledgling program in the 1960's toward eventually complete autonomy and financial rewards, despite resistance from other members of the medical community and the Nursing profession itself. Facing a patchwork of varying, sometimes inconsistent and restrictive regulations on the state and federal levels, Nurse Practitioners face serious issues and challenges in several arenas, including but not limited to ethical, legal, political and educational concerns, that hamper their abilities to provide the highest standard of patient care. However, Nurse Practitioners are now using the clout endowed by sheer numbers to promote greater autonomy, more equitable financial rewards and high standards of care.
Grant Proposal on Outcomes of Fibrinolytic Therapy Versus PCI
Evidence based medicine requires foundational inquiry and support. Heart disease, thrombolytic disease, pulmonary embolism, deep vein thrombosis, stroke and preliminary stroke occurrences and myocardial infarction are fundamentally significant challenges in medicine and community. Treatment of varied presentations of thrombolytic crisis deserve significant research inquiry and time given the severity of the potential outcomes and the numbers of individuals who seek treatment daily for heart disease and acute cardiac and venous crisis and the number of people who have both positive and negative medical and life outcomes during all levels of intervention. The various treatment options for acute and often potentially deadly cardiac crisis are often well tested and well established, yet they also require constant vigilance on the part of clinical researchers and practitioners to develop appropriate and best practices for best possible outcomes for patients. It is well established that outcomes of fibrinolytic therapy versus primary percutaneous coronary intervention (PCI) vary with the most important functions of PCI being the immediacy of its performance, hence the door-balloon initiative contending that PCI be performed within 90 minutes of entrance for acute ST segment elevation myocardial infarction (STEMI) yet further research must be conducted to reiterate the importance of fibrinolytic therapy in concordance with PCI and also as an alternative when the door-to-balloon window has been bridged over time, be it from time of event beginning or time of treatment exposure.